Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A scientific notebook and pen in a laboratory setting

Jun 6, 2026

Agilent Partners With OpenAI and BCG to Scale AI Across Products, Operations, and Customer Workflows

Agilent Technologies has entered into a strategic partnership with OpenAI and Boston Consulting Group (BCG) to enhance the integration of artificial intelligence (AI) within its operations and product offerings.This collaboration aims to leverage Agilent's scientific expertise and data resources alongside OpenAI's AI research capabilities and BCG's experience in enterprise transformation. The goal is to identify and scale AI applications that can improve Agilent's business processes and customer
Surgical gloves on a hospital supply table

Jun 6, 2026

IHH Healthcare Taps Infosys in a Seven-Year Deal to Build AI-Powered ERP Platform Across Global Hospital Network

IHH Healthcare has partnered with Infosys in a significant seven-year agreement to develop an AI-enhanced ERP platform aimed at streamlining operations across its extensive global network of healthcare facilities.The new system, leveraging Oracle technology, is designed to unify procurement and supply chain activities, improving operational efficiency and data-driven decision-making. With nearly 190 healthcare facilities, including 89 hospitals in 10 countries, IHH Healthcare is one of the large
A minimalist representation of a drug compound molecule in a dark color scheme.

Jun 6, 2026

Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) Is Down 14.8% After ASCO NSCLC Data Spotlight - Has The Bull Case Changed?

Sichuan Kelun-Biotech Biopharmaceutical recently faced a 14.8% decline following its presentations at the 2026 ASCO Annual Meeting, where it showcased promising data on its oncology pipeline, particularly for non-small cell lung cancer (NSCLC).The company highlighted findings from its Phase III and Phase II trials, notably the combination of sacituzumab tirumotecan and pembrolizumab, which demonstrated improved progression-free survival compared to pembrolizumab alone. Additionally, lunbotinib f
A minimalist illustration of a vaccine vial and virus silhouette in dark colors.

Jun 6, 2026

‘World-First’ AI-Designed Vaccine Enters Human Trial, Aiming to Protect Against Future Pandemic Threats

A groundbreaking AI-designed vaccine is entering human trials, aimed at enhancing preparedness for future pandemics by targeting multiple coronaviruses simultaneously.Researchers from the University of Cambridge have initiated the first successful human trial of a vaccine whose key antigen was entirely created using artificial intelligence. This innovative vaccine is designed to combat various coronaviruses, including current COVID-19 variants and animal strains that could potentially lead to fu
A hospital bed in a dimly lit room with a medical chart on the table.

Jun 6, 2026

Paras Healthcare Refiles INR 1,800 Cr IPO, Plans Expansion to 3,011 Beds by FY28

Paras Healthcare is making a renewed push to enter the public market with a proposed INR 1,800 crore IPO, aiming to expand its hospital bed capacity significantly by FY28.The company’s IPO plan includes a fresh issue of INR 500 crore and an offer for sale of up to INR 1,300 crore by existing shareholders. This marks Paras Healthcare's second attempt to list on Indian stock exchanges in under two years, following a previous attempt that fell through despite regulatory approval in 2024.Founded in
Flat illustration of siRNA molecule and AI model

Jun 6, 2026

How a US$2 Billion Generative AI RNAi Deal At Alnylam Pharmaceuticals (ALNY) Has Changed Its Investment Story

Alnylam Pharmaceuticals has entered a significant partnership with Inceptive Nucleics, valued at up to $2 billion, aimed at leveraging generative AI to enhance RNAi drug discovery. This collaboration includes an initial investment of $30 million and grants Alnylam access to advanced AI models and expertise, notably from Transformer co-inventor Jakob Uszkoreit, to improve siRNA design and overall research productivity.This partnership is poised to reshape Alnylam's investment narrative as it seek
A minimalist representation of a molecule and a computer chip, symbolizing AI in drug discovery.

Jun 6, 2026

NYB.AI Featured in NVIDIA GTC Taiwan

NYB.AI, an AI-driven drug discovery platform, has gained recognition at NVIDIA GTC Taiwan 2026, showcasing its innovative potential in the life sciences sector.Developed by Nanyang Biologics, NYB.AI was highlighted in the opening showcase video at the event, which featured select companies from the NVIDIA Inception ecosystem. This recognition underscores the growing global interest in integrating artificial intelligence with biology and high-performance computing to enhance drug discovery proces
A tissue sample on a laboratory countertop with a notebook in the background.

Jun 6, 2026

Is Tempus AI’s (TEM) New Oncology Tools Quietly Redefining Its Precision Medicine Moat?

Tempus AI is making significant strides in oncology with recent advancements that include FDA approval for its xT CDx tumor-only sequencing platform and the upcoming launch of its xH whole-genome test. These innovations are part of a broader strategy to integrate AI into precision medicine, aiming to create a comprehensive infrastructure for diagnostics and drug development.With the FDA's endorsement of the xT CDx platform, Tempus AI is poised to enhance its market position by potentially conver
A quantum encryption chip on a lab countertop in a dimly lit research lab.

Jun 6, 2026

Redwood AI Piles on the News Flow: Patent, Quantum Deal, and Government Cash

Redwood AI has recently generated significant investor interest, with its stock climbing nearly 10% following a series of strategic announcements. These developments encompass a quantum acquisition, a new patent, and government funding aimed at enhancing its capabilities in the life sciences sector.The most notable announcement involves Redwood AI's intention to acquire Quantum.IQ, a company specializing in quantum-resistant encryption. This acquisition, still subject to due diligence and regula
A minimalist illustration of a brain and circuit design representing AI in healthcare.

Jun 6, 2026

Philippines AI in Healthcare Market: Early Detection Revolution, Drug Discovery Acceleration & Universal Health Integration

The Philippines is witnessing significant growth in its AI healthcare market, driven by a collaborative effort among government entities, international pharmaceutical companies, and innovative healthtech startups. This surge aims to address persistent healthcare challenges through various AI applications, including medical imaging, telemedicine, and predictive analytics.The market is projected to grow from USD 194.85 million in 2025 to USD 1.44 billion by 2034, reflecting a remarkable compound a
A minimalist illustration of a dog and stethoscope on a dark background.

Jun 6, 2026

IDEXX Laboratories stock (US45168D1046): shares hover near recent highs ahead of valuation focus

IDEXX Laboratories is currently experiencing strong market interest as its shares hover near recent highs, prompting investors to evaluate its valuation amidst its earnings trajectory and competitive positioning in the veterinary diagnostics sector.The company, which specializes in veterinary diagnostics and is listed on Nasdaq under the ticker IDXX, has a market capitalization of approximately $44.55 billion as of June 4, 2026. This solidifies its status as a significant player in the animal he
A minimalist representation of a protein structure and energy system in a dark palette.

Jun 6, 2026

More leading researchers brought to the UK, while Horizon Europe performance strengthens in 2024 | Innovate UK

The UK is enhancing its appeal as a hub for scientific research by attracting ten leading international researchers, particularly in fields like clean energy and life sciences, through the Global Talent Fund.This initiative, supported by a £54 million investment, aims to bolster the UK’s research capabilities and align with its Modern Industrial Strategy. The recent cohort includes notable figures such as Professor Bryony DuPont, who will leverage AI to enhance energy systems, and Dr. Ivana Bukv